Works matching AstraZeneca PLC

Results: 986

IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis.

Published in:

Cancer Management & Research, 2018, v. 10, p. 6685, doi. 10.2147/CMAR.S179189

By:

Browning, Landon;
Patel, Megha R;
Horvath, Eli Bring;
Tawara, Ken;
Jorcyk, Cheryl L

Publication type:

Article

An evaluation of treatment options for lateral epicondylitis.

Published in:

Journal of Surgery & Medicine (JOSAM), 2020, v. 4, n. 12, p. 1182, doi. 10.28982/josam.755934

By:

Özcanyüz, Burç;
Oğur, Hasan Ulaş;
Seyfettinoğlu, Fırat;
Baydar, Mehmet;
Ozan, Fırat;
Müjde, Salih

Publication type:

Article

Acute coronary syndrome, angina, and myocardial infarction.

Published in:: Formulary, 2006, v. 41, n. 10, p. 540
Publication type:: Article

Drug Watch.

Published in:: 2006
Publication type:: Product Review

FDA: actions in brief.

Published in:: Formulary, 2006, v. 41, n. 9, p. 428
Publication type:: Article

FDA PANEL OKs NEWER ANTIPSYCHOTICS FOR CHILDREN.

Published in:: Psychiatry (1550-5952), 2009, v. 6, n. 6, p. 12
Publication type:: Article

ASTRAZENECA RECEIVES FDA COMPLETE RESPONSE LETTER ON SEROQUEL XR FOR GENERALIZED ANXIETY DISORDER.

Published in:: Psychiatry (1550-5952), 2009, v. 6, n. 3, p. 12
Publication type:: Article

Developing new drugs.

Published in:: 2014
Publication type:: Opinion

Ceftaroline fosamil.

Published in:: Australian Prescriber, 2013, v. 36, n. 3, p. 105
Publication type:: Article

Ticagrelor.

Published in:: Australian Prescriber, 2011, v. 34, n. 5, p. 158
Publication type:: Article

Seven days: 21-27 June 2013.

Published in:: Nature, 2013, v. 498, n. 7455, p. 412, doi. 10.1038/498412a
Publication type:: Article

Seven days: 3-9 February 2012.

Published in:: Nature, 2012, v. 482, n. 7384, p. 136, doi. 10.1038/482136a
Publication type:: Article

Pollution: Drug firm monitors waste water.

Published in:

2011

By:

Snape, Jason;
Lewis, Chris;
Murray-Smith, Richard

Publication type:

Letter

News briefing: 11 March 2010.

Published in:: Nature, 2010, v. 464, n. 7286, p. 146, doi. 10.1038/464146a
Publication type:: Article

Vimovo®: Fixed-dose naproxen/esomeprazole to treat arthritic symptoms.

Published in:: 2013
Publication type:: Product Review

Department of Health and Human Services, AstraZeneca to Develop Antibiotics.

Published in:

Clinical Infectious Diseases, 2015, v. 61, n. 11, p. i, doi. 10.1093/cid/civ889

By:

Kaye, Donald

Publication type:

Article

Business digest.

Published in:: Chemistry & Industry, 2017, v. 81, n. 9, p. 12, doi. 10.1002/cind.819_3.x
Publication type:: Article

Business digest.

Published in:: Chemistry & Industry, 2015, v. 79, n. 10, p. 19, doi. 10.1002/cind.7910_5.x
Publication type:: Article

Trial Offers Early Test Case for Personalized Medicine.

Published in:

JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 3, p. 136, doi. 10.1093/jncI/djn506

By:

Garber, Ken

Publication type:

Article

FDA, AstraZeneca Limit Distribution of Gefitinib.

Published in:

JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1031

By:

Hayasaka, Elana;
Zielinski, Sarah I.

Publication type:

Article

FDA Oncology Committee Debates Iressa's Status Following Negative Trial Results.

Published in:

JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 7, p. 473, doi. 10.1093/jnci/97.7.473

By:

Twombly, Renee

Publication type:

Article

Failing Survival Advantage in Crucial Trial, Future of Iressa Is in Jeopardy.

Published in:

JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 4, p. 249, doi. 10.1093/jnci/97.4.249

By:

Twombly, Renee

Publication type:

Article

Iressa Fails to Show Survival Benefit in Lung Cancer Trial.

Published in:

JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 2, p. 91

By:

Zielinski, Sarah L.

Publication type:

Article

CDC Committee Recommends FluMist for Under-5s.

Published in:: Clinical Infectious Diseases, 2007, v. 45, n. 12, p. iv, doi. 10.1086/524890
Publication type:: Article

MEMBER NETWORKS.

Published in:: TCE: The Chemical Engineer, 2014, n. 880, p. 54
Publication type:: Article

The chemical engineering project of the year award.

Published in:: TCE: The Chemical Engineer, 2011, n. 845, p. 60
Publication type:: Article

Kinesin inhibitor marches toward first-in-class pivotal trial.

Published in:

Nature Medicine, 2013, v. 19, n. 12, p. 1550, doi. 10.1038/nm1213-1550a

By:

Owens, Brian

Publication type:

Article

Drug companies hope to breathe life into asthma pipeline.

Published in:

Nature Medicine, 2011, v. 17, n. 6, p. 642, doi. 10.1038/nm0611-642b

By:

May, Mike

Publication type:

Article

Clinical drive prompts pharma and academia to partner up.

Published in:

Nature Medicine, 2011, v. 17, n. 1, p. 3, doi. 10.1038/nm0111-3

By:

Scudellari, Megan

Publication type:

Article

From the sponsors.

Published in:

Nature Medicine, 2002, v. 8, n. 11, p. 1208, doi. 10.1038/nm1102-1208

By:

O'Rangers, Eleanor A.

Publication type:

Article

256-OR: Substantial Cardiovascular Risk Reduction with Icosapent Ethyl Regardless of Diabetes Status or BMI: REDUCE-IT BMI.

Published in:

Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-256-OR

By:

BHATT, DEEPAK L.;
BRINTON, ELIOT A.;
STEG, PHILIPPE G.;
KETCHUM, STEVEN B.;
JULIANO, REBECCA A.;
JIAO, LIXIA;
DOYLE, RALPH T.;
GRANOWITZ, CRAIG;
TARDIF, JEAN-CLAUDE;
BALLANTYNE, CHRISTIE M.

Publication type:

Article

6-LB: Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-6-LB

By:

CLEGG, LINDSAY E.;
PENLAND, ROBERT C.;
BOULTON, DAVID W.;
BACHINA, SRINIVAS;
THURESSON, MARCUS;
HEERSPINK, HIDDO L.;
GUSTAVSON, STEPHANIE;
SJöSTRöM, C. DAVID;
RUGGLES, JAMES A.;
HERNANDEZ, ADRIAN F.;
BUSE, JOHN B.;
MENTZ, ROBERT J.;
HOLMAN, RURY R.

Publication type:

Article

55-OR: Oral Semaglutide vs. Liraglutide and Placebo in T2D: PIONEER 4.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-55-OR

By:

PRATLEY, RICHARD E.;
AMOD, ASLAM;
HOFF, SOREN T.;
KADOWAKI, TAKASHI;
LINGVAY, ILDIKO;
NAUCK, MICHAEL A.;
PEDERSEN, KAREN BOJE;
SAUGSTRUP, TRINE;
MEIER, JURIS J.

Publication type:

Article

456-P: The REMOVAL Trial: Effect of Metformin on Markers of Cardiometabolic Risk in Patients with Type 1 Diabetes.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-456-P

By:

WELSH, PAUL;
GREENLAW, NICOLA;
COLHOUN, HELEN;
CHATURVEDI, NISHI;
FORD, IAN;
HRAMIAK, IRENE;
HUGHES, ALUN D.;
JENKINS, ALICIA;
KLEIN, BARBARA E.K.;
KLEIN, RONALD;
BROUWERS, MARTIJN;
ROSSING, PETER;
STEHOUWER, COEN D.;
SATTAR, NAVEED;
PETRIE, JOHN R.

Publication type:

Article

345-OR: A Retrospective U.S. Real-World Evidence Study on Glycemic Goal Achievement within 2 Years Post-Basal Insulin Initiation.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-345-OR

By:

PENG, XUEJUN V.;
HUNT, PHILLIP R.;
DEX, TERRY A.;
LUBWAMA, ROBERT;
SKOLNIK, NEIL;
BLONDE, LAWRENCE

Publication type:

Article

1134-P: Efficacy of iGlarLixi in Adults with Type 2 Diabetes Inadequately Controlled on Two or More Oral Antidiabetic Agents.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1134-P

By:

SKOLNIK, NEIL;
NIEMOELLER, ELISABETH;
SOUHAMI, ELISABETH;
MENEGHINI, LUIGI

Publication type:

Article

1106-P: Predictive Modeling Suggests Subgroup Effects for Severe Hypoglycemia in T2DM Patients Treated with Gla-300 vs. IDeg: The LIGHTNING Study.

Published in:

Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1106-P

By:

HRAMIAK, IRENE;
HALUZIK, MARTIN;
WESTERBACKA, JUKKA;
BOSNYAK, ZSOLT;
ELIASSON, BJORN;
BLONDE, LAWRENCE;
BAILEY, TIMOTHY S.

Publication type:

Article

Impact of patent expiry on the top five pharmaceutical companies.

Published in:: Journal of Generic Medicines, 2004, v. 1, n. 4, p. 381, doi. 10.1057/palgrave.jgm.4940045
Publication type:: Article

Clinical trials: More trials, fewer tribulations.

Published in:

Nature, 2014, v. 509, n. 7502, p. S55, doi. 10.1038/509S55a

By:

Eisenstein, Michael

Publication type:

Article

Market watch: Biopharma deal-making in 2014: a record year for M&A value.

Published in:

Nature Reviews Drug Discovery, 2015, v. 14, n. 2, p. 84, doi. 10.1038/nrd4536

By:

Micklus, Amanda;
Muntner, Steven

Publication type:

Article

Market watch: Upcoming catalysts in Q1 2015.

Published in:

Nature Reviews Drug Discovery, 2015, v. 14, n. 1, p. 9, doi. 10.1038/nrd4517

By:

Uribe, Armando

Publication type:

Article

Deal watch: Lilly buys back into the BACE race for Alzheimer's disease.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 11, p. 804, doi. 10.1038/nrd4469

By:

Cully, Megan

Publication type:

Article

Court clears the way for Nexium alternative.

Published in:

Nature Reviews Drug Discovery, 2014, v. 13, n. 2, p. 94, doi. 10.1038/nrd4240

By:

Harrison, Charlotte

Publication type:

Article

Deal watch: AstraZeneca bets on FibroGen's anaemia drug.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 10, p. 730, doi. 10.1038/nrd4135

By:

Flight, Monica Hoyos

Publication type:

Article

Integrin inhibitors go with the gut.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 411, doi. 10.1038/nrd4037

By:

Holmes, David

Publication type:

Article

Menelas Pangalos.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 6, p. 418, doi. 10.1038/nrd4044

By:

Mullard, Asher

Publication type:

Article

European Lead Factory opens for business.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 3, p. 173, doi. 10.1038/nrd3956

By:

Mullard, Asher

Publication type:

Article

Patent watch.

Published in:

Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 94, doi. 10.1038/nrd3948

By:

Harrison, Charlotte

Publication type:

Article

News in brief.

Published in:: Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 739, doi. 10.1038/nrd3865
Publication type:: Article

News in brief.

Published in:: Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 663, doi. 10.1038/nrd3840
Publication type:: Article